Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Gold history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Aditya Birla Sun Life Gold Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹97.98 |
| 12 Apr 2015 | ₹85.07 |
| 31 May 2016 | ₹90.34 |
| 19 Jul 2017 | ₹88.85 |
| 07 Sep 2018 | ₹93.38 |
| 27 Oct 2019 | ₹117.82 |
| 15 Dec 2020 | ₹146.94 |
| 03 Feb 2022 | ₹142.48 |
| 25 Mar 2023 | ₹175.66 |
| 12 May 2024 | ₹211.15 |
| 01 Jul 2025 | ₹277.20 |
| 20 Aug 2026 | ₹441.57 |
| Metric | Aditya Birla Sun Life · Direct NAV ₹46.94 High risk ★★★☆☆ | Category median FoF Domestic · 151 funds |
|---|---|---|
| +57.04% | +8.79% | |
| +37.26% | +14.76% | |
| +25.74% | +11.89% | |
| +16.16% | +12.34% | |
| +11.51% | +11.30% | |
| +32.70% | — | |
| +11.28% | +13.06% | |
| +10.79% | +10.96% | |
| +10.74% | +10.76% | |
| Risk | ||
| 22.23% | 15.95% | |
| 1.38 | 0.81 | |
| 2.01 | 1.14 | |
| -27.30% | -19.45% | |
| Gold | — | |
| -1.92% | +1.81% | |
| 1.07 | 0.94 | |
| 99.8% | 98.0% | |
| 101.4% | 93.1% | |
| 0.21% | 0.17% | |
| ₹1,754Cr | ₹228.08Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 11% | |
| Priya Sridhar · 1.6y | — | |
| 02 Jan 2013 | — | |
| — | — | |
| — | — | |
| -0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.